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Production of mouse human hybrids by fusion of mouse myeloma cells with human 
lymphoid cells  has  been  well  documented  since  the  early  studies  of Schwaber  and 
Cohen (1,  2). These hybrids do, however, lack stability and display a  preferential  loss 
of human chromosomes in the days after fusion  (3)  in a  manner that  appears  to be 
nonrandom  (4,  5).  Their  chromosomal  instability  has  proved  valuable  for  gene 
mapping studies,  including experiments  that  have resulted  in the provisional assign- 
ment of human  heavy chain genes to chromosome  14  (5-7).  On the other hand,  the 
preferential  loss of human chromosomes has made it difficult to use the hybrid lines 
for sustained production of human immunoglobulin (Ig) (8, 9). Moreover, the problem 
has  not  yet  been  solved  by  substituting  myeloma  cell  lines  of human  origin  and, 
although several  groups have successfully produced  human-human  hybrids  (10  12), 
long-term antibody-secreting cell lines have not to our knowledge been reported. 
We describe  here  three  mouse-human  lines  derived  from a  single  fusion between 
the mouse myeloma line NS-1  and  human tonsillar  lymphocytes. One of these lines 
has continued to secrete human Ig over a  2-yr period in culture. The other lines were 
less  stable  and  eventually  stopped  secreting  Ig.  Nonsecreting  lines  were  examined 
using isoenzyme assays to determine whether chromosome  14 had been lost.  Because 
the majority of nonsecreting hybrids still had chromosome 14, and therefore appeared 
to retain the structural genes for human Ig, they were stimulated with mitogens in an 
attempt  to regain  Ig secretion.  Lipopolysaccharide  (LPS) 1 stimulation  of three  non- 
secreting cell lines resulted in sustained Ig production, indicating that the cessation of 
Ig secretion in those hybrid cells may be caused by factors other than loss of structural 
genes.  The ability  to regain  Ig secretion  through  mitogen  stimulation  suggests  that 
mouse-human  hybridomas  may  still  be  of potential  value  as  a  source  of human 
monoclonal antibody. 
Materials  and Methods 
Cell Culture.  NS-1 cells were grown in Dulbecco's modified Eagle's medium (DME), (Gibco 
Laboratories, Grand Island Biological Co., Grand Island, NY) containing 10% fetal calf serum 
(FCS)  (Flow Laboratories, Stanmore, New South Wales, Australia)  and antibiotics (penicillin 
* Supported by grants from the Clive and  Vera Ramaciotti  Foundations and  the Cancer  Research 
Committee, University of Sydney. 
i Abbreviations used in this paper: DME, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; HAT, 
hypoxanthine, aminopterin, thymidine; LPS, lipopolysaccharide; PBS, phosphate-buffered saline; PWM, 
pokeweed mitogen; RIA, radioimmunoassay; SDME, supplemented Dulbecco's modified Eagle's medium. 
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100  IU/ml  and  streptomycin  100  /~g/ml).  After  fusion,  hybrid  cells  were  grown  in  DME 
containing 2 ×  10  -4 M  hypoxanthine, 8  ×  10  -7 M  aminopterin, and 3.2 ×  10  -5 M  thymidine 
(HAT) with FCS and antibiotics as above. Established hybrid lines were cultured in supple- 
mented  DME  (SDME),  DME  with  added  Hepes  (2.38  g/liter)  and  glucose  (3.5  g/liter). 
Tonsillar lymphocytes were grown in RPMI  1640 containing 10% FCS, penicillin and strep- 
tomycin as above, and gentamycin (50/~g/ml). Macrophage-conditioned medium consisted of 
SDME- 10% FCS taken from flasks in which~mouse peritoneal exudate cells (initial concentration 
2.5 ×  105 cells/ml) had been grown for 3-4 d. 
Cell Fusion and Hybrid Selection.  Tonsillar lymphocytes were prepared as described previously 
(8) and cultured for 4 d  in flasks at 2.5 ×  106 cells/ml with a  1:200 dilution of stock pokeweed 
nitrogen (PWM)  (Gibco Laboratories).  Cultured tonsillar lymphocytes (108 cells) were  fused 
with  10  7  P3/NSI/I-Ag4-1  cells  (NS-1)  in  the  presence  of polyethylene  glycol-4000  (Ajax, 
Sydney, Australia). After fusion, cells were incubated at 2 ×  106 cells/ml in a  75-cm  2 flask for 
12 h, and then distributed in 48  ×  2-ml cultures in DME-10%  FCS-HAT medium. Normal 
mouse peritoneal exudate cells were added at a concentration of 1 X  105 cells/ml. 
Cloning.  Hybrid cells were  cloned by  limit  dilution in 96-well  microtiter plates  (Linbro 
Chemical Co., Hamden, CT). 
Cell Culture with  LPS.  Hybrid cells were grown in 2-ml cultures in SDME-10% FCS with 
25% macrophage-conditioned medium at an initial concentration of either  1 ×  104 or 5 ×  104 
cells/ml. LPS from Salmonella typhimurium (Sigma Chemical Co., St. Louis, MO)  was added at 
concentrations between 5 and 50 ~g/ml. 
Radioimmunoassay.  Supernatants from hybrid cell cultures were screened for production of 
human  Ig  by  solid-phase  radioimmunoassay  (RIA)  in  polyvinylchloride microtiter  plates 
(Cooke  Laboratories,  Dynatech  Corp.,  Alexandria,  VA).  In  the  initial screening of hybrid 
cultures, goat IgG to human Ig (Oxford Laboratories, Foster City, CA) was bound to the plate, 
and human Ig in culture supernatants was detected  with an 125I-labeled  F(ab')2 fragment of 
goat antiserum to human Ig (Oxford Laboratories). In subsequent assays, rabbit IgG to human 
IgG (Dako,  Copenhagen, Denmark) was bound to the plate, and human IgG production by 
established hybrid lines was detected in an inhibition assay using 125I-labeled  affinity-purified 
human IgG (13).  All results were  quantitated with reference to  known standards of human 
IgG. 
Detection of Histocompatibility Antigens and Human Ig on the Surface of Hybrid Cells.  The presence 
of surface human IgG and human t¢ or ?~ light chains on hybrid cells was detected by direct 
immunofluorescence using either  a  fluorescein conjugated  F(ab')z  fragment  of goat  IgG  to 
human IgG  (MN  55318;  Kallestad  Laboratories,  Austin, TX),  or  fluorescein or rhodamine 
conjugated F(ab')2 fragments of burro Ig to human ~¢ or ~ light chains (Kallestad Laboratories). 
All washes and incubations were carried out in RPMI  1640 containing 0.1% NAN3. 
Histocompatibility antigens were  detected  by indirect immunofluorescence. Washed  cells 
were incubated for 30 min at 4°C with a  1:500 dilution of 2A 1, a mouse monoclonal antibody 
to HLA A, B, C  public specificities (the generous gift of Dr.  P. Beverley, University College, 
London, England) or with a  1:100 dilution of 1203 Y, a  mouse monoclonal antibody to H-2  a 
histocompatibility  antigens  (the  generous  gift  of  Prof.  I.  F.  C.  McKenzie,  University of 
Melbourne, Melbourne, Australia). After incubation, the cells were  washed  three times and 
then incubated for 30 min at 4°C with a fluorescein-conjugated F(ab')2 fragment of sheep anti- 
mouse Ig (New England Nuclear, Boston, MA). Stained cells were washed three times, applied 
to microscope slides in 90% glycerol in phosphate-buffered saline (PBS) (pH 8.6), and examined 
under oil immersion with a Zeiss fluorescent microscope (Carl Zeiss Inc., New York). Over 200 
cells were counted on each slide. 
Chromosome Preparations.  Hybrid cells were arrested in metaphase during logarithmic growth 
by the addition of 1/~l/ml of colcemid (0.05 g/ml in Hank's balanced salt solution) followed by 
60 min incubation at 37°C. The cells were then washed, resuspended in 1 ml of medium, and 
exposed to hypotonic conditions by the addition of 6 ml of 0.075 M  KCI. After 15 min, the cells 
were centrifuged and fixed by four washes in 3:1  (vol/vol) methanol/glacial acetic acid. The 
cell  pellet  was  resuspended  in  0.5  ml  3:1  (vol/vol)  methanol/glacial  acetic  acid,  and  the 
suspension was  dropped  onto cold  glass  slides and  spread  by rapid  air drying.  Slides were 
stained with Giemsa stain or for centromeric heterochromatin (C-banding) after the method of 1382  RESTIMULATION OF SECRETION  BY  MOUSE-ttUMAN  ItYBRIDS 
Boone and co-workers (14). 
Isoenzyme Analysis for Human Chromosomes 6 and 14.  The presence of human chromosoines 6 
and  14  in cloned mouse-human  hybrids was sought  by assaying for the  isoenzyme markers 
glyoxalase I (chromosome 6) and nucleoside phosphorylase (chromosome 14)  (15). Cell lysates 
from selected secreting and nonsecreting hybrid lines were analysed by starch gel or cellulose 
acetate electrophoresis followed by enzyme-specific staining procedures using a paper overlay. 
Normal human lymphocytes and the murine plasmacytoma NS-1 were incorporated as controls 
in each assay. 
Results 
Production  and  Characterization  of Ig-secreting  Hybrids.  Fusion  of  PWM-stimulated 
human tonsillar lymphocytes with NS-1 yielded three cloned human Ig-secreting lines 
designated B1-29,  A2-31, and  E2-42.  These  cloned  lines varied both  quantitatively 
and qualitatively in the human  Ig secreted. All failed to express HLA while retaining 
the H-2 d haplotype of the murine parent  line (Table I). 
Karyological studies carried out on B1-29, the only hybrid line to remain secreting 
human  Ig >18  mo after initial isolation, revealed a  mean  of 122  chromosomes/cell, 
more than  twice the  number  of chromosomes  found  in  NS-1.  Counts  on  C-banded 
metaphase  preparations  indicated  that  at  least  22  of these  122  chromosomes  were 
putatively of human origin. 
Recloning  of B1-29  18 mo After Initial Isolation.  B 1-29 was the only hybrid line that 
continued  to  secrete  human  Ig  18  mo  after  initial  isolation.  At  this  stage,  it  was 
recloned  by  limit  dilution  (Fig.  1 A),  and  each  resulting  subclone was  assessed  for 
human  IgG secretion  with  an  inhibition  RIA  for  human  IgG.  Nonsecreting  clones 
were  defined  as  cultures  with  <0.1  /.tg of human  IgG/ml,  whereas  high-secreting 
clones  were  cultures  with  >0.8  /zg/ml  human  IgG.  403  subclones  of  B1-29  were 
assayed, of which 24% were nonsecreting and only 7% were high-secreting clones (Fig. 
1 A). Two  high-secreting subclones  (H1  and  H3)  were  then  recloned  (Fig.  1 B,  C), 
and  this procedure was repeated yet again with  H 1-4 and  H3-4,  two  high-secreting 
subclones obtained  from  the cloning of H1  and  H3,  respectively (Fig.  1 D,  E).  The 
frequency of high-secreting clones was dramatically enhanced  by this procedure. All 
41  subclones  assayed  from  H3-4  secreted  high  levels  of human  IgG  (>1  ~g/ml), 
whereas 57% of the 27 clones assayed from H 1-4 were high secretors. The recloning of 
B 1-29 produced a  panel of nonsecreting and high-secreting subclones that were then 
TAULE  I 
Characterization of Three Mouse-Human Hybrid Clones Secreting Human Ig 
Doubling  Secretion of  Ig  Light chain type§  HLA  u  H-2  d 
Cell line  time  human IgG*  subclass:~ 
h  /*g/lO ~  cells 
A2-31  34  15.0  yl  ND¶  -  + 
B 1-29  46  3.7  yl  Human X  -  + 
E2-42  33  0.7  "1'4  Human )~  -  + 
NS- 1  22  0  --  Mouse x  -  + 
* Detected by an inhibition-type RIA using lzSI-labeled,  affinity-purified human IgG. 
Determined by immunodiffusion using subclass specific goat anti-human antisera. 
§ Determined by direct immunofluorescence using fluorescein- or rhodamine-conjugated  burro anti-human 
Kor~. 
II Determined by direct immunofluorescence (see Materials and Methods). 
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FIG.  1.  The frequency of human Ig secretion in B1-29 after recloning. (a) 403 subclones from  B1- 
29;  (b)  60 subclones from  H 1 and  (c)  36 subclones from  H3  (H 1 and  H3  were two high-secreting 
subclones derived from B 1-29);  (d)  27 subclooes from tl 1-4,  a  high-secreting subclone derived from 
Ill;  (e)  41 subclones from H3-4, a  high-secreting subclone derived from It3. 
examined for the presence of surface Ig and chromosomes 6 and  14. 
Surface Ig on Secreting and Nonsecreting Subclones of B1-29.  Selected subclones of B 1-29 
were examined by direct immunofluorescence for the presence of surface human IgG 
(Table II). Only 2 out of 30 nonsecreting subclones of B1-29 had detectable surface 
human  IgG.  Loss of secretion  by these mouse-hybrid lines  thus  tended  to correlate 
with  loss of surface Ig. The  high-secreting lines  expressed  variable  levels  of surface 
human  IgG,  with  between  0  and  55%  of total  cells  counted  showing  fluorescent 
staining. 
Detection of Human Chromosomes 6 and 14 in Mouse-Human Hybrids.  The three original 
mouse-human hybrid lines and selected high-secreting and nonsecreting subclones of 
B1-29 were examined for the presence of human chromosomes 6 and  14 by assaying 
for glyoxalase I  and  nucleoside  phosphorylase, respectively.  All  three  original  lines 
lacked human glyoxalase I  (Table III), which implies that  human chromosome 6 is 
absent.  B 1-29 and E2-42 contained human nucleoside phosphorylase, the marker for 
chromosome 14, but this was absent  in A2-31. At this time, B1-29 was the only cell 1384  RESTIMULATION  OF  SECRETION  BY  MOUSE-ttUMAN  ttYBRIDS 
TABLE  II 
Mouse-Human Hybrids." Surface and Secreted Human IgG 
Cell line  Description 
Percent 
Secretion  cells with  of human  surface hu- 
man IgG*  IgG~c 
ttg/ml 
B 1-29  Original cell lines  25%  0.6 
A2-31  0%  0 
E2-42  11%  0 
L1  to L7  32 nonsecreting subclones  0(7,  0 
L10 to L32  of Bl-29  0%  0 
L8  1  '7c  (1 
L9  8%  0 
tt 1  high-secreting  subclones  14%  1.3 
H2  of B1-29  11%  0.7 
tt3  6%  0.8 
H4  8%  1.6 
tf5  2'7,  0.8 
tt6  55%  1.3 
H 7  0%  2.0 
* Determined  by  direct  immunofluorescence with  a  fluorescein-conjugated 
F(ab')z fragment of goat antiserum to human IgG. 
:~ These values were determined using an inhibition-type RIA  18 mo after the 
three original cell lines had first been isolated. 
TABLE  III 
Species of Nucleoside Phosphorylase in Mouse-Human Hybri&" 
Nucleoside phosphorylase  Glyoxalase 
Cell type  (chrmnosome 14)  I (chromo- 
some 6) 
ttuman tonsil  ttuman  tfuman 
NS- 1  Mouse  Mnuse 
B 1-29"  l tuman and mouse  Mouse 
E2-42  tluman and nmuse  Mouse 
A2-31  Mouse  Mouse 
B1-29 nonsecreting subclones  tluman and mouse (13):~  Mouse (4) 
B 1-29 secreting subclones  Human and mouse (7)  Mouse (3) 
*  B1-29 was the only original  line still secreting human IgG when assays for 
isoenzymes were carried out. 
:~ The numbers in brackets refer to numbers of B 1-29 subclones examined. 
line still  secreting  human  Ig.  All subclones  of B 1-29 examined  had  human  nucleoside 
phosphorylase  but  lacked  human  glyoxalase  I, regardless  of whether  they  had  stopped 
secreting  Ig or not. 
Retrieval of  Human IgG Secretion in Nonsecreting  Hybrids by Stimulation with LPS.  Because 
nonsecreting  hybrids  appeared  to  retain  chromosome  14,  an  attempt  was  made  to 
retrieve  Ig  secretion.  Two  of  the  original  lines,  A2-31  and  E2-42,  which  had  lost RAISON, WALKER,  HALNAN, BRISCOE,  AND  BASTEN  1385 
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Fro.  2.  The effect of LPS concentration on human Ig secretion in three mouse-human hybrid lines 
after 24 h  in culture. Initial cell concentration was 1 ×  104 cells/ml. (a) BI-29; (b) E2-42;  (c) A2-31. 
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Flc.  3.  The effect of 10/~g/ml of LPS on human Ig secretion for 5 d  in culture. The three mouse- 
human hybrid lines were set up at an initial concentration of 1 ×  104 cells/ml. O, B1-29 L8; O, E2- 
42; &, A2-31. 
secretion,  and  B1-29-LS,  a  nonsecreting  subclone  of B1-29,  were  grown  in  2-ml 
duplicate cultures at an initial  concentration of either  1 ×  104 or 5  X  104 cells/ml  in 
the presence of 5-50/~g/ml LPS. Cells from these three lines not only did not secrete, 
but also had little or no surface human IgG (Table II). 
Samples  of culture  supernatants  were  taken  on  days  1,  2,  and  5  and  assayed 
quantitatively  for the presence of human IgG. All cultures set up at  1 X  104 cells/ml 
responded  to  LPS  by  secreting  human  IgG,  whereas  there  was  little  response  in 1386  RESTIMULATION  OF SECRETION BY  MOUSE-IIUMAN I1YBRI1)S 
cultures set up at 5 ×  104 cells/ml.  Human IgG secretion was readily detectable after 
24 h culture  (Fig.  2)  and was greatest  in the presence of 10-20 >g/ml LPS, reaching 
>0.7  ~g/ml  human  IgG.  Thus,  the  response  to  LPS  was  highly  dose  dependent. 
Secretion  of human  IgG by  B1.29.L8  and  E2.42  continued  until  at  least  day  5  of 
culture, whereas A2.31 peaked between days  1 and 2, and IgG could not be detected 
on day 5 (Fig.  3). This did not seem to be caused by death of cells  in the cultures, as 
viability on day 5 was normally >80%. 
Discussion 
This  paper  describes  the  features  of three  mouse-human  hybrid  lines  secreting 
human  Ig of unknown  specificity.  They were  obtained  from  a  fusion  between  the 
mouse myeloma line NS- 1 and human tonsillar lymphocytes that had been stimulated 
for 4  d  in  vitro  with  PWM.  The  hybrid  lines  secreted  human  IgG of the  71  or T4 
subclass with )~-type light chains (Table I). ~Dne line, B 1-29, has continued to secrete 
human  IgG for 2  yr in  culture,  but  the  other  two  lines  lost  secretion  after  several 
months. 
Loss of secretion of human Ig is a  common occurrence in  mouse-human hybrids. 
Thus,  we  have  previously  found  that  hybrids  between  NS-1  and  human  tonsillar 
lymphocytes stimulated in vitro with influenza virus initially secreted human antibody 
specific for the stimulating virus but failed to retain this capacity through subsequent 
cloning procedures  (8). Nevertheless,  long-term human Ig-secreting hybrids like  the 
B1-29  line  can  occasionally  be  produced.  Stable  hybrids  that  secrete  human  Ig 
reactive against the Forssman antigen (16), antigens on human mammary carcinoma 
cells  (17), and human keyhole limpet hemocyanin (18) have recently been reported. 
Mouse-human  hybrids  tend  to  retain  murine  chromosomes  and  loose  human 
chromosomes after fllsion (3). Loss of the chromosome bearing the structural genes for 
human Ig provides one possible explanation for the cessation of Ig secretion. Although 
disadvantageous with  respect  to sustained  production of human Ig, the preferential 
loss  of human  chromosomes  from  these  hybrids  provides  a  useful  tool  for  gene 
mapping studies.  On  this  basis,  Croce et  al.  (5  7)  have suggested  that  the  human 
heavy chain genes reside on chromosome 14,  despite  an  earlier  assignment to chro- 
mosome 6 (19, 20). 
We have investigated whether the loss of human Ig secretion by our mouse-human 
hybrids could be attributed to a loss of the chromosome bearing the relevant structural 
genes.  To do this, cells from the secreting B 1-29 line were cloned repeatedly to obtain 
a  panel  of stable  high-secreting and nonsecreting subclones. The majority of nonse- 
creting  subclones  proved  to  have  lost  surface  Ig  (Table  |I).  Representative  B1-29 
subclones and cells from the three original hybrid lines were examined for the presence 
of chromosomes 6 and  14 using the  isoenzyme markers  glyoxalase I  and  nucleoside 
phosphorylase, which are assigned to these chromosomes (15). This approach proved 
to be more satisfactory than karyological analysis, because of the very high numbers 
of chromosomes present  in  the hybrid cells;  B1-29, for example, had a  mean of 122 
chromosomes. None of the mouse-human hybrids examined expressed human glyox- 
alase I, implying the absence of chromosome 6;  this finding is in agreement with the 
absence  of HLA antigens  on  the  three  original  hybrid  lines,  although  all  of them 
displayed surface H-2  d antigens (Table I). E2-42 and all subclones of B 1-29 examined, 
whether secreting or nonsecreting, had  human nucleoside phosphorylase, indicating RAISON, WALKER, HALNAN, BRISCOE, AND BASTEN  1387 
the presence of human chromosome  14.  The remaining line A2-31, which no longer 
secreted or expressed surface human Ig, lacked human nucleoside phosphorylase. The 
presence of chromosome 14 and the absence of chromosome 6 in all secreting subclones 
of  B1-29  is  in  agreement  with  the  assignment  of  human  heavy  chain  genes  to 
chromosome 14  (5-7) rather than to chromosome 6  (19, 20). On the other hand, we, 
like Croce et al. (6), observed that many hybrids retained chromosome 14 but did not 
secrete (Table III). Two possible inferences may be drawn from these findings. Firstly, 
loss  of Ig secretion  may be  caused  by  the  loss  of a  regulatory  gene  rather  than  a 
structural gene. Alternatively, but less likely, the chromosomal assignment for human 
heavy chain  genes may be incorrect.  To distinguish  between these two possibilities, 
attempts were made to restimulate nonsecreting cell lines to Ig secretion using LPS 
alone, or PWM  with  added  human  T  cells.  These agents were selected as LPS  is a 
well known polyclonal activator for murine  B cells  (21)  and  PWM  with T  cell help 
can  activate ~human  B  cells  (22).  Furthermore,  both  of  them  will  stimulate  Ig 
production in malignant as well as normal B cells. For instance, PWM in the presence 
of T  cells  has  been  shown  to  stimulate  peripheral  blood  mononuclear  cells  from 
chronic lymphocytic leukemia patients to secrete Ig (23, 24:). Similarly, Gronowicz et 
al.  (25)  have induced IgM secretion in a  murine B cell tumour with LPS. 
Culture of the nonsecreting mouse human hybrids with PWM and different ratios 
of normal human T  cells failed to induce the secretion of human Ig (data not shown). 
Irradiation of the human T  cells in this system, for the purpose of removing suppressor 
cells  (26),  also  failed to result  in  human  Ig secretion  (data not  shown).  By contrast, 
treatment with LPS did induce the secretion of human Ig from previously nonsecreting 
mouse-human lines (Fig. 2).  In other words, the hybrids appeared to resemble mouse 
cells more closely than human cells in their response to mitogens. The level of secretion 
depended  on  the  number  of cells  used,  as  a  maximum response  was  seen  with  an 
initial  cell  concentration  of  1  ×  104  cells/ml,  whereas  cells  cultured  at  higher 
concentrations  (5  ×  104  cells/ml)  yielded  much  lower amounts  of Ig.  Hybrid cells 
reacted to LPS by secretion of human  IgG at levels of up to 0.7 btg/ml, the greatest 
response occurring  at  a  concentration  of 10 ~tg/ml  LPS.  A  high  response was  seen 
after  1  d  in  cuRure ,  and  in  two  of the  three  lines  examined,  this  response  was 
maintained  over  the  next  4  d  (Fig.  3).  Surprisingly  A2-31,  which  lacks  human 
nucleoside phosphorylase, did produce Ig, albeit transiently. The ability to restimulate 
A2-31,  despite  the  apparent  absence  of chromosome  14,  may  have  a  number  of 
explanations. For example, a translocation may have occurred involving chromosome 
14, with subsequent  loss of genes for nucleoside phosphorylase and retention of genes 
for human  Ig. Alternatively, the  nucleoside  phosphorylase gene may not  be pheno- 
typically active in  A2-31,  leading  to  the  false assumption  that  chromosome  14 was 
absent. Whatever the explanation  (if either is correct), these data illustrate the need 
for caution in using enzyme markers for gene assignment. 
The  capacity  of LPS  to  restimulate  Ig  secretion  in  nonsecreting  mouse-human 
hybrids  demonstrates  that  loss  of secretion  is  not  necessarily  due  to  loss  of  the 
structural genes for Ig. Instead, there may be a  loss of genes regulating Ig synthesis or 
secretion, a  defect that can be overcome by treatment with the appropriate mitogen. 
From  the  practical  point  of  view,  mitogen  treatment  may  provide  a  means  of 
reclaiming Ig secretion  in  hybrids  that  have become nonfunctional.  This  approach 
may be relevant not only to interspecies hybrids, but also to human-human hybrids, 1388  RESTIMULATION OF SECRETION  BY  MOUSE-HUMAN  ttYBRIDS 
where loss of secretion in the cloning stages also appears to be a  problem (E. Adams 
and G. McCaughan,  personal conmmnication). 
Summary 
Three  cloned  mouse-human  lines  (B1-29,  E2-42,  and  A2-31)  secretmg  human 
immunoglobulin  (Ig) were obtained from a  fusion between the mouse myeloma line 
NS-1  and human  tonsillar lymphocytes stimulated in vitro with  pokeweed mitogen. 
One line, B 1-29, has continued to secrete human  IgG for a  period of 2 yr in culture. 
This  line  was  recloned  three  times  to  give  a  panel  of secreting  and  nonsecreting 
subclones. Most of the nonsecreting subclones had also lost surface Ig. 
The structural genes for human  Ig heavy chains have been provisionally assigned 
to chromosome  14, which also encodes the enzyme nucleoside phosphorylase. Human 
nucleoside phosphorylase was  detected in  all secreting and  nonsecreting B1-29  sub- 
clones, indicating the presence of human  chromosome  14.  The retention of chromo- 
some  14 in nonsecreting clones implied that  the structural  genes for human  Ig were 
still present.  Using one  of the B1-29  nonsecreting clones and  the original cell lines, 
A2-31 and E2-42,  which had stopped secreting, an attempt was made to restimulate 
the  secretion  of human  Ig  with  mitogens.  A2-31  was  unique  among  the  cell  lines 
examined,  in  that  chromosome  14  could  not  be  detected  by an  isoenzyme  marker. 
Lipopolysaccharide, at an optimum dose of 10 ~g/ml, restimulated these nonsecreting 
hybrid lines to secrete human  IgG in levels up to 0.7/~g/ml.  Loss of Ig secretion may 
not therefore be caused by loss of Ig structural genes. 
We  thank  Miss J.  Watson  for  valuable assistance with  chromosomal  preparations, Miss  E. 
Adams for expert help with  the culture of human  lymphocytes, and  Miss D.  Bartimote for 
careful preparation of the manuscript. 
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